The FDA said in a statement that it had determined that one of the two approved vaccines, Ixchiq (Valneva SE), which contains ...

In a report released today, from Stifel Nicolaus maintained a Buy rating on Valneva, with a price target of €9.50. The company’s shares opened today at €3.78. Elevate Your I ...